scholarly article | Q13442814 |
P356 | DOI | 10.1086/653497 |
P8608 | Fatcat ID | release_fmea5ieqcjeqrjnwmm2mly63sq |
P932 | PMC publication ID | 2913975 |
P698 | PubMed publication ID | 20533872 |
P5875 | ResearchGate publication ID | 44659507 |
P50 | author | James M Oleske | Q39273703 |
Susan Brogly | Q45413807 | ||
Jack Moye | Q56856588 | ||
P2093 | author name string | Miriam C Chernoff | |
Kathleen M Malee | |||
Russell B Van Dyke | |||
William A Meyer | |||
Wendy G Mitchell | |||
Marilyn J Crain | |||
Peggy R Borum | |||
George R Seage Iii | |||
Heather M Ford-Chatterton | |||
P2860 | cites work | Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors | Q24536268 |
Maternal and infant factors associated with failure to thrive in children with vertically transmitted human immunodeficiency virus-1 infection: the prospective, P2C2 human immunodeficiency virus multicenter study | Q28365722 | ||
Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues | Q28373514 | ||
The medical dictionary for regulatory activities (MedDRA). | Q33542532 | ||
Epidemiology and treatment of mitochondrial disorders | Q34386766 | ||
Prevalence of mitochondrial DNA disease in adults | Q34691723 | ||
Mitochondrial toxicity of nrti antiviral drugs: an integrated cellular perspective | Q35550221 | ||
Genetic features of mitochondrial respiratory chain disorders | Q35593189 | ||
Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis. | Q35606742 | ||
Toxicity of nucleoside analogues used to treat AIDS and the selectivity of the mitochondrial DNA polymerase | Q35607523 | ||
Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. | Q35909841 | ||
Mitochondrial dysfunction and antiretroviral nucleoside analog toxicities: what is the evidence? | Q36239813 | ||
Mitochondrial dysfunction in AIDS and its treatment | Q81110778 | ||
Mitochondrial DNA levels of peripheral blood mononuclear cells and subcutaneous adipose tissue from thigh, fat and abdomen of HIV-1 seropositive and negative individuals | Q81191235 | ||
Impact of nucleoside reverse transcriptase inhibitors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy | Q36313228 | ||
Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy. | Q36555731 | ||
Molecular genetic and clinical aspects of mitochondrial disorders in childhood | Q36766110 | ||
In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children | Q36800856 | ||
Impact of nucleoside reverse transcriptase inhibitors on mitochondrial DNA and RNA in human skeletal muscle cells | Q36803931 | ||
Mechanisms of antiretroviral therapy-induced mitochondrial dysfunction | Q37447274 | ||
Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV-infected mothers on antiretroviral therapy | Q37492507 | ||
Incidence of opportunistic and other infections in HIV-infected children in the HAART era. | Q38467275 | ||
Highly active antiretroviral therapy (HAART)-associated lactic acidosis: in vitro effects of combination of nucleoside analogues and protease inhibitors on mitochondrial function and lactic acid production. | Q39299561 | ||
Greater and more rapid depletion of mitochondrial DNA in blood of patients treated with dual (zidovudine+didanosine or zidovudine+zalcitabine) vs. single (zidovudine) nucleoside reverse transcriptase inhibitors | Q39391662 | ||
Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study | Q40396667 | ||
Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors | Q40693184 | ||
Detecting life-threatening lactic acidosis related to nucleoside-analog treatment of human immunodeficiency virus-infected patients, and treatment with L-carnitine | Q42596690 | ||
Mitochondrial disorders: a proposal for consensus diagnostic criteria in infants and children | Q44213543 | ||
Factors Associated With Mitochondrial Dysfunction in Circulating Peripheral Blood Lymphocytes From HIV-Infected People | Q44591425 | ||
The clinical spectrum of mitochondrial disease in 75 pediatric patients | Q44644971 | ||
Mitochondrial effects of antiretroviral therapies in asymptomatic patients. | Q44811840 | ||
Lack of recurrence of hyperlactatemia in HIV-infected patients switched from stavudine to abacavir or zidovudine | Q44954259 | ||
Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals | Q45051217 | ||
Role of mitochondria in HIV lipoatrophy: insight into pathogenesis and potential therapies | Q46667574 | ||
Minimum birth prevalence of mitochondrial respiratory chain disorders in children | Q47835071 | ||
Changes in body composition and mitochondrial nucleic acid content in patients switched from failed nucleoside analogue therapy to ritonavir-boosted indinavir and efavirenz. | Q50725587 | ||
Mitochondrial DNA depletion and respiratory chain enzyme deficiencies are present in peripheral blood mononuclear cells of HIV-infected patients with HAART-related lipodystrophy. | Q51650745 | ||
In utero nucleoside reverse transcriptase inhibitor exposure and cancer in HIV-uninfected children: an update from the pediatric AIDS clinical trials group 219 and 219C cohorts. | Q51942604 | ||
A model of the nuclear control of mitochondrial DNA replication. | Q52017733 | ||
Antiretroviral Treatment in Pediatric HIV Infection in the United States From Clinical Trials to Clinical Practice | Q58285674 | ||
Antiretroviral nucleoside and nucleotide analogues and mitochondria | Q61928346 | ||
Mitochondrial disease criteria: Diagnostic applications in children | Q62671343 | ||
Effects of coding dictionary on signal generation: a consideration of use of MedDRA compared with WHO-ART | Q74318099 | ||
Toward a pharmacogenetic understanding of nucleotide and nucleoside analogue toxicity | Q79327315 | ||
Changes in the peripheral blood mtDNA levels in naive patients treated by different nucleoside reverse transcriptase inhibitor combinations and their association with subsequent lipodystrophy | Q79690105 | ||
Tissue-specific associations between mitochondrial DNA levels and current treatment status in HIV-infected individuals | Q79817086 | ||
Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients | Q80239731 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | anti-retroviral agent | Q50430310 |
P304 | page(s) | 291-301 | |
P577 | publication date | 2010-07-01 | |
P1433 | published in | Journal of Infectious Diseases | Q4051141 |
P1476 | title | Possible mitochondrial dysfunction and its association with antiretroviral therapy use in children perinatally infected with HIV | |
P478 | volume | 202 |
Q36941650 | Cardiac effects in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents: a view from the United States of America |
Q34881120 | Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers |
Q89615834 | Cellular stress responses and dysfunctional Mitochondrial-cellular senescence, and therapeutics in chronic respiratory diseases |
Q30402510 | Comparison of auditory brainstem response in HIV-1 exposed and unexposed newborns and correlation with the maternal viral load and CD4+ cell counts |
Q34150710 | HIV Infection, Inflammation, Immunosenescence, and Aging |
Q30416349 | Hearing loss among HIV-seropositive and HIV-seronegative men and women |
Q30523969 | Hearing loss in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents |
Q35848277 | Language impairment in children perinatally infected with HIV compared to children who were HIV-exposed and uninfected |
Q47201399 | Larger Subcortical Gray Matter Structures and Smaller Corpora Callosa at Age 5 Years in HIV Infected Children on Early ART. |
Q35073479 | Neurocognitive functioning in a Romanian cohort of young adults with parenterally-acquired HIV-infection during childhood |
Q39244930 | Performance of clinical criteria for screening of possible antiretroviral related mitochondrial toxicity in HIV-infected children in Accra |
Q36509694 | Physical fitness in children infected with the human immunodeficiency virus: associations with highly active antiretroviral therapy |
Q37111533 | Short communication: The relationship between mitochondrial dysfunction and insulin resistance in HIV-infected children receiving antiretroviral therapy. |
Q36929688 | The Use of the Medical Dictionary for Regulatory Activities in the Identification of Mitochondrial Dysfunction in HIV-Infected Children |
Q38366365 | Tolerance of the newborn to antiretroviral drug exposure in utero |
Search more.